[{"edinetCode":"E05379","endDate":"2017\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1481.0,"averageTemporaryStaff":403.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5494340.0,"sharesOwendPercent":0.608,"outstandingShares":null,"numberOfSubsidiary":15.0,"bps":589.71,"equityRatio":0.217,"cashAndCashEquivalents":3734000000.0,"assets":24540000000.0,"currentAssets":8361000000.0,"fixedAsset":16169000000.0,"tangibleFixedAssets":7011000000.0,"intangibleFixedAssets":6170000000.0,"investmentAndOtherAssets":2988000000.0,"liabilities":18639000000.0,"currentLiabilities":9801000000.0,"shorTermDept":null,"currentPortionOfBonds":154000000.0,"currentPortionOfLongTermDebt":2698000000.0,"fixedLiabilities":8838000000.0,"bonds":463000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7044000000.0,"netAsset":5900000000.0,"capitalStock":5342000000.0,"capital":1174000000.0,"capitalSurplus":1160000000.0,"accumulatedEarnings":3008000000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-12000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":52949000000.0,"costOfSales":45731000000.0,"grossProfit":7218000000.0,"sgaExpenses":6775000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":8000000.0,"operatingIncome":442000000.0,"nonOperatingIncome":193000000.0,"nonOperatingExpenses":312000000.0,"interestExpense":127000000.0,"ordinaryProfit":324000000.0,"extraordinaryGain":64000000.0,"extraordinaryLoss":387000000.0,"incomeBeforeTax":1000000.0,"incomeTaxes":251000000.0,"netIncome":-249000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":7000000.0,"comprehensiveIncome":-240000000.0,"eps":0.85,"dilutedEps":0.83,"dividendPerShare":null,"per":604.7,"roe":0.001,"cashFlowFromOperatingActivities":2103000000.0,"depreciationAndCashflowFromOperatingActivities":637000000.0,"cashFlowFromInvestingActivities":-871000000.0,"cashFlowFromFinancialActivities":-816000000.0,"changesInCashAndCashEquivalents":415000000.0,"列1":"asr","submitDate":"2017\/8\/25","stockCode":2796,"accountingYear":"第31期(自　平成28年６月１日　至　平成29年５月31日)","accountingYearStart":"2016\/6\/1","accountingYearEnd":"2017\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2018\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1504.0,"averageTemporaryStaff":396.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5412540.0,"sharesOwendPercent":0.599,"outstandingShares":null,"numberOfSubsidiary":13.0,"bps":585.97,"equityRatio":0.218,"cashAndCashEquivalents":3643000000.0,"assets":24265000000.0,"currentAssets":9122000000.0,"fixedAsset":15135000000.0,"tangibleFixedAssets":6503000000.0,"intangibleFixedAssets":5642000000.0,"investmentAndOtherAssets":2990000000.0,"liabilities":18640000000.0,"currentLiabilities":10769000000.0,"shorTermDept":null,"currentPortionOfBonds":154000000.0,"currentPortionOfLongTermDebt":3244000000.0,"fixedLiabilities":7870000000.0,"bonds":309000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6175000000.0,"netAsset":5624000000.0,"capitalStock":5279000000.0,"capital":1174000000.0,"capitalSurplus":1252000000.0,"accumulatedEarnings":2852000000.0,"treasuryStock":null,"valuationAndConversionAdjustments":17000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":54562000000.0,"costOfSales":46612000000.0,"grossProfit":7950000000.0,"sgaExpenses":6771000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":13000000.0,"operatingIncome":1179000000.0,"nonOperatingIncome":109000000.0,"nonOperatingExpenses":195000000.0,"interestExpense":106000000.0,"ordinaryProfit":1092000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":679000000.0,"incomeBeforeTax":414000000.0,"incomeTaxes":622000000.0,"netIncome":-208000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-28000000.0,"comprehensiveIncome":-178000000.0,"eps":-3.19,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":-0.005,"cashFlowFromOperatingActivities":1330000000.0,"depreciationAndCashflowFromOperatingActivities":626000000.0,"cashFlowFromInvestingActivities":-527000000.0,"cashFlowFromFinancialActivities":-894000000.0,"changesInCashAndCashEquivalents":-91000000.0,"列1":"asr","submitDate":"2018\/8\/29","stockCode":2796,"accountingYear":"第32期(自　平成29年６月１日　至　平成30年５月31日)","accountingYearStart":"2017\/6\/1","accountingYearEnd":"2018\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2019\/2\/28","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.214,"cashAndCashEquivalents":null,"assets":24138000000.0,"currentAssets":9249000000.0,"fixedAsset":14880000000.0,"tangibleFixedAssets":6426000000.0,"intangibleFixedAssets":5353000000.0,"investmentAndOtherAssets":3099000000.0,"liabilities":18612000000.0,"currentLiabilities":9342000000.0,"shorTermDept":90000000.0,"currentPortionOfBonds":154000000.0,"currentPortionOfLongTermDebt":2509000000.0,"fixedLiabilities":9269000000.0,"bonds":1714000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6151000000.0,"netAsset":5526000000.0,"capitalStock":5153000000.0,"capital":1229000000.0,"capitalSurplus":1307000000.0,"accumulatedEarnings":2615000000.0,"treasuryStock":null,"valuationAndConversionAdjustments":17000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":38510000000.0,"costOfSales":33206000000.0,"grossProfit":5303000000.0,"sgaExpenses":5022000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":281000000.0,"nonOperatingIncome":81000000.0,"nonOperatingExpenses":143000000.0,"interestExpense":63000000.0,"ordinaryProfit":218000000.0,"extraordinaryGain":7000000.0,"extraordinaryLoss":43000000.0,"incomeBeforeTax":182000000.0,"incomeTaxes":298000000.0,"netIncome":-115000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-110000000.0,"comprehensiveIncome":-116000000.0,"eps":-12.14,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/4\/15","stockCode":2796,"accountingYear":null,"accountingYearStart":"2018\/6\/1","accountingYearEnd":"2019\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2019\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1455.0,"averageTemporaryStaff":368.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5449240.0,"sharesOwendPercent":0.59,"outstandingShares":null,"numberOfSubsidiary":10.0,"bps":572.74,"equityRatio":0.219,"cashAndCashEquivalents":4393000000.0,"assets":24217000000.0,"currentAssets":9601000000.0,"fixedAsset":14608000000.0,"tangibleFixedAssets":6290000000.0,"intangibleFixedAssets":5175000000.0,"investmentAndOtherAssets":3141000000.0,"liabilities":18597000000.0,"currentLiabilities":9347000000.0,"shorTermDept":null,"currentPortionOfBonds":154000000.0,"currentPortionOfLongTermDebt":2577000000.0,"fixedLiabilities":9250000000.0,"bonds":1637000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6150000000.0,"netAsset":5619000000.0,"capitalStock":5287000000.0,"capital":1229000000.0,"capitalSurplus":1307000000.0,"accumulatedEarnings":2749000000.0,"treasuryStock":null,"valuationAndConversionAdjustments":4000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":51728000000.0,"costOfSales":44386000000.0,"grossProfit":7342000000.0,"sgaExpenses":6702000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":13000000.0,"operatingIncome":640000000.0,"nonOperatingIncome":132000000.0,"nonOperatingExpenses":181000000.0,"interestExpense":82000000.0,"ordinaryProfit":590000000.0,"extraordinaryGain":7000000.0,"extraordinaryLoss":197000000.0,"incomeBeforeTax":400000000.0,"incomeTaxes":410000000.0,"netIncome":-10000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":23000000.0,"comprehensiveIncome":-22000000.0,"eps":2.55,"dilutedEps":2.24,"dividendPerShare":null,"per":201.2,"roe":0.004,"cashFlowFromOperatingActivities":895000000.0,"depreciationAndCashflowFromOperatingActivities":531000000.0,"cashFlowFromInvestingActivities":-501000000.0,"cashFlowFromFinancialActivities":354000000.0,"changesInCashAndCashEquivalents":749000000.0,"列1":"asr","submitDate":"2019\/8\/29","stockCode":2796,"accountingYear":"第33期(自　平成30年６月１日　至　令和元年５月31日)","accountingYearStart":"2018\/6\/1","accountingYearEnd":"2019\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2019\/8\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.229,"cashAndCashEquivalents":null,"assets":25096000000.0,"currentAssets":10177000000.0,"fixedAsset":14912000000.0,"tangibleFixedAssets":6308000000.0,"intangibleFixedAssets":5091000000.0,"investmentAndOtherAssets":3512000000.0,"liabilities":19145000000.0,"currentLiabilities":10344000000.0,"shorTermDept":120000000.0,"currentPortionOfBonds":154000000.0,"currentPortionOfLongTermDebt":2628000000.0,"fixedLiabilities":8800000000.0,"bonds":1637000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5691000000.0,"netAsset":5951000000.0,"capitalStock":5750000000.0,"capital":1229000000.0,"capitalSurplus":1437000000.0,"accumulatedEarnings":3082000000.0,"treasuryStock":null,"valuationAndConversionAdjustments":3000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":12913000000.0,"costOfSales":11100000000.0,"grossProfit":1812000000.0,"sgaExpenses":1707000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":105000000.0,"nonOperatingIncome":61000000.0,"nonOperatingExpenses":26000000.0,"interestExpense":18000000.0,"ordinaryProfit":140000000.0,"extraordinaryGain":null,"extraordinaryLoss":7000000.0,"incomeBeforeTax":132000000.0,"incomeTaxes":-329000000.0,"netIncome":462000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":462000000.0,"comprehensiveIncome":461000000.0,"eps":48.4,"dilutedEps":44.91,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/10\/15","stockCode":2796,"accountingYear":null,"accountingYearStart":"2019\/6\/1","accountingYearEnd":"2020\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2019\/11\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5523640.0,"sharesOwendPercent":0.583,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.238,"cashAndCashEquivalents":4067000000.0,"assets":24573000000.0,"currentAssets":9807000000.0,"fixedAsset":14759000000.0,"tangibleFixedAssets":6266000000.0,"intangibleFixedAssets":4996000000.0,"investmentAndOtherAssets":3497000000.0,"liabilities":18500000000.0,"currentLiabilities":9732000000.0,"shorTermDept":null,"currentPortionOfBonds":166000000.0,"currentPortionOfLongTermDebt":2649000000.0,"fixedLiabilities":8767000000.0,"bonds":1548000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5765000000.0,"netAsset":6073000000.0,"capitalStock":5832000000.0,"capital":1229000000.0,"capitalSurplus":1437000000.0,"accumulatedEarnings":3216000000.0,"treasuryStock":-51000000.0,"valuationAndConversionAdjustments":3000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":25761000000.0,"costOfSales":22047000000.0,"grossProfit":3714000000.0,"sgaExpenses":3193000000.0,"salaryAndBenefit":607000000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":521000000.0,"nonOperatingIncome":75000000.0,"nonOperatingExpenses":73000000.0,"interestExpense":38000000.0,"ordinaryProfit":522000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":63000000.0,"incomeBeforeTax":459000000.0,"incomeTaxes":-137000000.0,"netIncome":597000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":595000000.0,"comprehensiveIncome":596000000.0,"eps":62.41,"dilutedEps":53.84,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":683000000.0,"depreciationAndCashflowFromOperatingActivities":257000000.0,"cashFlowFromInvestingActivities":-258000000.0,"cashFlowFromFinancialActivities":-750000000.0,"changesInCashAndCashEquivalents":-325000000.0,"列1":"q2r","submitDate":"2020\/1\/14","stockCode":2796,"accountingYear":null,"accountingYearStart":"2019\/6\/1","accountingYearEnd":"2020\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2020\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1555.0,"averageTemporaryStaff":396.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5543040.0,"sharesOwendPercent":0.597,"outstandingShares":null,"numberOfSubsidiary":10.0,"bps":613.2,"equityRatio":0.226,"cashAndCashEquivalents":4464000000.0,"assets":25206000000.0,"currentAssets":10676000000.0,"fixedAsset":14524000000.0,"tangibleFixedAssets":6332000000.0,"intangibleFixedAssets":5285000000.0,"investmentAndOtherAssets":2906000000.0,"liabilities":19259000000.0,"currentLiabilities":10036000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":128000000.0,"currentPortionOfLongTermDebt":2681000000.0,"fixedLiabilities":9223000000.0,"bonds":1509000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6037000000.0,"netAsset":5946000000.0,"capitalStock":5693000000.0,"capital":1229000000.0,"capitalSurplus":1437000000.0,"accumulatedEarnings":3197000000.0,"treasuryStock":-172000000.0,"valuationAndConversionAdjustments":3000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":51030000000.0,"costOfSales":43592000000.0,"grossProfit":7437000000.0,"sgaExpenses":6402000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":9000000.0,"operatingIncome":1034000000.0,"nonOperatingIncome":122000000.0,"nonOperatingExpenses":133000000.0,"interestExpense":74000000.0,"ordinaryProfit":1023000000.0,"extraordinaryGain":63000000.0,"extraordinaryLoss":267000000.0,"incomeBeforeTax":819000000.0,"incomeTaxes":238000000.0,"netIncome":580000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":577000000.0,"comprehensiveIncome":580000000.0,"eps":61.11,"dilutedEps":46.38,"dividendPerShare":null,"per":10.8,"roe":0.105,"cashFlowFromOperatingActivities":1572000000.0,"depreciationAndCashflowFromOperatingActivities":522000000.0,"cashFlowFromInvestingActivities":-734000000.0,"cashFlowFromFinancialActivities":-766000000.0,"changesInCashAndCashEquivalents":71000000.0,"列1":"asr","submitDate":"2020\/8\/27","stockCode":2796,"accountingYear":"第34期(自　令和元年６月１日　至　令和２年５月31日)","accountingYearStart":"2019\/6\/1","accountingYearEnd":"2020\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2020\/8\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.226,"cashAndCashEquivalents":null,"assets":24318000000.0,"currentAssets":10092000000.0,"fixedAsset":14222000000.0,"tangibleFixedAssets":6342000000.0,"intangibleFixedAssets":5034000000.0,"investmentAndOtherAssets":2846000000.0,"liabilities":18566000000.0,"currentLiabilities":9509000000.0,"shorTermDept":120000000.0,"currentPortionOfBonds":128000000.0,"currentPortionOfLongTermDebt":2500000000.0,"fixedLiabilities":9057000000.0,"bonds":1509000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5928000000.0,"netAsset":5751000000.0,"capitalStock":5499000000.0,"capital":1229000000.0,"capitalSurplus":1437000000.0,"accumulatedEarnings":3012000000.0,"treasuryStock":-180000000.0,"valuationAndConversionAdjustments":3000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":12881000000.0,"costOfSales":11198000000.0,"grossProfit":1683000000.0,"sgaExpenses":1698000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":-15000000.0,"nonOperatingIncome":39000000.0,"nonOperatingExpenses":25000000.0,"interestExpense":19000000.0,"ordinaryProfit":0.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":null,"incomeBeforeTax":1000000.0,"incomeTaxes":56000000.0,"netIncome":-55000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-55000000.0,"comprehensiveIncome":-55000000.0,"eps":-5.96,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/10\/15","stockCode":2796,"accountingYear":null,"accountingYearStart":"2020\/6\/1","accountingYearEnd":"2021\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2020\/11\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5584580.0,"sharesOwendPercent":0.598,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.243,"cashAndCashEquivalents":2785000000.0,"assets":23610000000.0,"currentAssets":9196000000.0,"fixedAsset":14410000000.0,"tangibleFixedAssets":6315000000.0,"intangibleFixedAssets":4898000000.0,"investmentAndOtherAssets":3196000000.0,"liabilities":17640000000.0,"currentLiabilities":8868000000.0,"shorTermDept":null,"currentPortionOfBonds":66000000.0,"currentPortionOfLongTermDebt":2426000000.0,"fixedLiabilities":8772000000.0,"bonds":1482000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5712000000.0,"netAsset":5969000000.0,"capitalStock":5724000000.0,"capital":1251000000.0,"capitalSurplus":1458000000.0,"accumulatedEarnings":3195000000.0,"treasuryStock":-180000000.0,"valuationAndConversionAdjustments":3000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":25666000000.0,"costOfSales":21871000000.0,"grossProfit":3795000000.0,"sgaExpenses":3269000000.0,"salaryAndBenefit":583000000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":525000000.0,"nonOperatingIncome":87000000.0,"nonOperatingExpenses":76000000.0,"interestExpense":39000000.0,"ordinaryProfit":536000000.0,"extraordinaryGain":25000000.0,"extraordinaryLoss":90000000.0,"incomeBeforeTax":471000000.0,"incomeTaxes":348000000.0,"netIncome":122000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":127000000.0,"comprehensiveIncome":122000000.0,"eps":13.73,"dilutedEps":11.87,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-19000000.0,"depreciationAndCashflowFromOperatingActivities":293000000.0,"cashFlowFromInvestingActivities":-690000000.0,"cashFlowFromFinancialActivities":-968000000.0,"changesInCashAndCashEquivalents":-1678000000.0,"列1":"q2r","submitDate":"2021\/1\/14","stockCode":2796,"accountingYear":null,"accountingYearStart":"2020\/6\/1","accountingYearEnd":"2021\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2021\/2\/28","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.236,"cashAndCashEquivalents":null,"assets":24185000000.0,"currentAssets":9785000000.0,"fixedAsset":14397000000.0,"tangibleFixedAssets":6407000000.0,"intangibleFixedAssets":4688000000.0,"investmentAndOtherAssets":3301000000.0,"liabilities":18250000000.0,"currentLiabilities":9568000000.0,"shorTermDept":160000000.0,"currentPortionOfBonds":66000000.0,"currentPortionOfLongTermDebt":2476000000.0,"fixedLiabilities":8682000000.0,"bonds":1482000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5591000000.0,"netAsset":5935000000.0,"capitalStock":5693000000.0,"capital":1251000000.0,"capitalSurplus":1458000000.0,"accumulatedEarnings":3182000000.0,"treasuryStock":-198000000.0,"valuationAndConversionAdjustments":3000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":38459000000.0,"costOfSales":32626000000.0,"grossProfit":5833000000.0,"sgaExpenses":5071000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":761000000.0,"nonOperatingIncome":123000000.0,"nonOperatingExpenses":272000000.0,"interestExpense":55000000.0,"ordinaryProfit":612000000.0,"extraordinaryGain":26000000.0,"extraordinaryLoss":92000000.0,"incomeBeforeTax":546000000.0,"incomeTaxes":440000000.0,"netIncome":106000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":114000000.0,"comprehensiveIncome":105000000.0,"eps":12.27,"dilutedEps":9.98,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/4\/14","stockCode":2796,"accountingYear":null,"accountingYearStart":"2020\/6\/1","accountingYearEnd":"2021\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2021\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1546.0,"averageTemporaryStaff":404.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5694780.0,"sharesOwendPercent":0.612,"outstandingShares":null,"numberOfSubsidiary":10.0,"bps":646.66,"equityRatio":0.243,"cashAndCashEquivalents":4604000000.0,"assets":24724000000.0,"currentAssets":10546000000.0,"fixedAsset":14175000000.0,"tangibleFixedAssets":6434000000.0,"intangibleFixedAssets":4464000000.0,"investmentAndOtherAssets":3276000000.0,"liabilities":18392000000.0,"currentLiabilities":9392000000.0,"shorTermDept":null,"currentPortionOfBonds":27000000.0,"currentPortionOfLongTermDebt":2538000000.0,"fixedLiabilities":9000000000.0,"bonds":1482000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5950000000.0,"netAsset":6331000000.0,"capitalStock":6013000000.0,"capital":1251000000.0,"capitalSurplus":1476000000.0,"accumulatedEarnings":3494000000.0,"treasuryStock":-208000000.0,"valuationAndConversionAdjustments":-1000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":52324000000.0,"costOfSales":44256000000.0,"grossProfit":8067000000.0,"sgaExpenses":6821000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":22000000.0,"operatingIncome":1246000000.0,"nonOperatingIncome":448000000.0,"nonOperatingExpenses":405000000.0,"interestExpense":75000000.0,"ordinaryProfit":1288000000.0,"extraordinaryGain":26000000.0,"extraordinaryLoss":112000000.0,"incomeBeforeTax":1202000000.0,"incomeTaxes":782000000.0,"netIncome":419000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":426000000.0,"comprehensiveIncome":414000000.0,"eps":45.83,"dilutedEps":34.64,"dividendPerShare":null,"per":16.9,"roe":0.073,"cashFlowFromOperatingActivities":1945000000.0,"depreciationAndCashflowFromOperatingActivities":606000000.0,"cashFlowFromInvestingActivities":-1076000000.0,"cashFlowFromFinancialActivities":-728000000.0,"changesInCashAndCashEquivalents":140000000.0,"列1":"asr","submitDate":"2021\/8\/27","stockCode":2796,"accountingYear":"第35期(自　令和２年６月１日　至　令和３年５月31日)","accountingYearStart":"2020\/6\/1","accountingYearEnd":"2021\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2021\/8\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.252,"cashAndCashEquivalents":null,"assets":23578000000.0,"currentAssets":9648000000.0,"fixedAsset":13928000000.0,"tangibleFixedAssets":6325000000.0,"intangibleFixedAssets":4269000000.0,"investmentAndOtherAssets":3333000000.0,"liabilities":17317000000.0,"currentLiabilities":8891000000.0,"shorTermDept":null,"currentPortionOfBonds":27000000.0,"currentPortionOfLongTermDebt":2409000000.0,"fixedLiabilities":8426000000.0,"bonds":1482000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5400000000.0,"netAsset":6261000000.0,"capitalStock":5944000000.0,"capital":1251000000.0,"capitalSurplus":1476000000.0,"accumulatedEarnings":3427000000.0,"treasuryStock":-210000000.0,"valuationAndConversionAdjustments":-1000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":13062000000.0,"costOfSales":11023000000.0,"grossProfit":2039000000.0,"sgaExpenses":1721000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":317000000.0,"nonOperatingIncome":40000000.0,"nonOperatingExpenses":22000000.0,"interestExpense":17000000.0,"ordinaryProfit":335000000.0,"extraordinaryGain":null,"extraordinaryLoss":42000000.0,"incomeBeforeTax":293000000.0,"incomeTaxes":230000000.0,"netIncome":62000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":63000000.0,"comprehensiveIncome":62000000.0,"eps":6.83,"dilutedEps":5.18,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/10\/15","stockCode":2796,"accountingYear":null,"accountingYearStart":"2021\/6\/1","accountingYearEnd":"2022\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0},{"edinetCode":"E05379","endDate":"2021\/11\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5833570.0,"sharesOwendPercent":0.624,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.268,"cashAndCashEquivalents":3254000000.0,"assets":23192000000.0,"currentAssets":9735000000.0,"fixedAsset":13455000000.0,"tangibleFixedAssets":6392000000.0,"intangibleFixedAssets":4075000000.0,"investmentAndOtherAssets":2986000000.0,"liabilities":16693000000.0,"currentLiabilities":8332000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2365000000.0,"fixedLiabilities":8360000000.0,"bonds":1482000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5384000000.0,"netAsset":6499000000.0,"capitalStock":6208000000.0,"capital":1274000000.0,"capitalSurplus":1529000000.0,"accumulatedEarnings":3614000000.0,"treasuryStock":-210000000.0,"valuationAndConversionAdjustments":-2000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":25903000000.0,"costOfSales":21757000000.0,"grossProfit":4145000000.0,"sgaExpenses":3357000000.0,"salaryAndBenefit":591000000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":788000000.0,"nonOperatingIncome":87000000.0,"nonOperatingExpenses":61000000.0,"interestExpense":35000000.0,"ordinaryProfit":814000000.0,"extraordinaryGain":21000000.0,"extraordinaryLoss":60000000.0,"incomeBeforeTax":775000000.0,"incomeTaxes":520000000.0,"netIncome":254000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":250000000.0,"comprehensiveIncome":252000000.0,"eps":26.94,"dilutedEps":20.34,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":17000000.0,"depreciationAndCashflowFromOperatingActivities":298000000.0,"cashFlowFromInvestingActivities":-337000000.0,"cashFlowFromFinancialActivities":-1031000000.0,"changesInCashAndCashEquivalents":-1350000000.0,"列1":"q2r","submitDate":"2022\/1\/14","stockCode":2796,"accountingYear":null,"accountingYearStart":"2021\/6\/1","accountingYearEnd":"2022\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05379","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":815,"settlementDate":"2022\/5\/31","submitterName":"ファーマライズホールディングス株式会社","submitterNameEnglish":"Pharmarise Holdings Corporation","submitterNameKana":"ファーマライズホールディングスカブシキガイシャ","location":"中野区中央一丁目３８番１号","industory":"サービス業","corporateNumber":5010000000000.0}]